TARGET-IBD: A longitudinal observational study of patients undergoing therapy for inflammatory bowel disease (IBD)

Go Back to All Clinical Trials

TARGET-IBD: A longitudinal observational study of patients undergoing therapy for inflammatory bowel disease (IBD)

Brief description of study

This is a 5-year, longitudinal, observational study of adult and pediatric patients (age 2 and above) undergoing IBD therapy designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a biospecimen repository will also be included so that translational studies of viral resistance, genomics, and biomarkers of response may be performed. Also, the right to collect retrospective data on these IBD patients will be reserved

Clinical Study Identifier: s18-00055

Principal Investigator: David P Hudesman.

Other Investigator: Shannon Chang.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies